Vasculitis and Giant Cell Arteritis News

In this video, Audra Horomanski, MD, discusses the importance of collaborative care in the treatment and maintenance of patients with vasculitis.

In this video, Audra Horomanski, MD, spoke with Healio about the impact vasculitis has on the management of pregnancy.

In this video, Audra Horomanski, MD, discusses highlights in vasculitis treatment and management from recent conferences.

Celltrion USA has submitted a Biologics License Application to the FDA for its tocilizumab biosimilar candidate CT-P47, according to a press release.

SAN DIEGO — Maintaining immunosuppression with or without low-dose glucocorticoids is superior to withdrawing both therapies in preventing relapses in IgG4-related disease, according to data presented at ACR Convergence 2023.

SAN DIEGO — Patients with primary systemic vasculitis who received a third or additional doses of a COVID-19 vaccine demonstrated a reduced risk for breakthrough infection, according to data presented at ACR Convergence 2023.

Dismantling the popular misconception that giant cell arteritis only occurs in white individuals is critical to providing timely diagnosis and care to all patients who may have the disease, regardless of race or ethnicity.

In this episode of Meeting Mic, we bring you Healio’s top headlines from ACR Convergence 2023.

SAN DIEGO — Approximately two-thirds of patients with ANCA-associated vasculitis report having neurological involvement, according to data presented at ACR Convergence 2023.

SAN DIEGO — Pregnant patients with vasculitis demonstrate an increased frequency of spontaneous abortion and preterm delivery vs. healthy controls, according to data presented at ACR Convergence 2023.